Melanoma cells were shown to be composed of heterogeneous cancer cells that, when expressing high levels of KDM5B, are resistant to therapy such as MAPK inhibition, giving rise to tumor repopulation after initial therapy (Roesch et al., 2010). The gene discussed is KDM5B; the disease is neoplasm.